6-K
Basel Medical Group Ltd (BMGL)
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
Washington,D.C. 20549
Form6-K
REPORTOF FOREIGN PRIVATE ISSUER
PURSUANTTO RULE 13a-16 OR 15d-16
UNDERTHE SECURITIES EXCHANGE ACT OF 1934
Forthe month of August 2025
CommissionFile Number: 001-42527
BaselMedical Group Ltd
6Napier Road,
Unit#02-10/11 Gleneagles Medical Centre
Singapore258499
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Resignationof Chief Partnership Officer
Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) has received a letter of resignation from its Group Chief Partnership Officer, Mr. Vincent Teo. The Company is presently determining the terms of separation with Mr. Teo. The Company would like to thank Mr. Teo for his service to the Company during his tenure.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Basel Medical Group Ltd | ||
|---|---|---|
| By: | /s/ Darren Yen Feng Chhoa | |
| Name: | Dr. Darren Yen Feng Chhoa | |
| Title: | Chief Executive Officer | |
| Date: August 13, 2025 |